Symrise schedules third-quarter results for October 28. Symrise stock falls 1.57 percent

Published on 10/26/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2025 revenue was EUR 4.929 billion. Symrise stock stood at EUR 100.40 on October 26, 2026, down 1.57 percent versus Xetra's EUR 102.00 close.

Reporting date and valuation

Symrise scheduled its third-quarter statement for October 28, 2026.
Fiscal 2025 revenue was EUR 4.929 billion and the EBITDA margin was 21.90 percent.
Symrise stock stood at EUR 100.40 on October 26, 2026, down 1.57 percent versus the Xetra close of EUR 102.00 on October 23, 2026.
The stock traded at 37.71 times earnings with a market capitalization of EUR 13.8 billion.

Symrise, DE000SYM9999, Illustration mit AI erstellt.

Symrise (ISIN DE000SYM9999) has scheduled its third-quarter statement for October 28, 2026, giving investors a defined near-term date for the next operating update. The company's investor calendar also lists a virtual management roadshow on the same date, according to Symrise. The latest Xetra quote stood at EUR 100.40 on October 26, 2026 at 5:19 p.m. CET, down 1.57 percent versus the Xetra close of EUR 102.00 on October 23, 2026.

Revenue and margin set the baseline

Symrise reported fiscal 2025 revenue of EUR 4.929 billion, organic growth of 2.80 percent and an EBITDA margin of 21.90 percent. The company said the margin figure excludes an impairment at associated company Swedencare, a detail that matters when investors compare the upcoming quarterly statement with the prior year. Fiscal 2025 earnings per share were EUR 3.67, while the dividend was EUR 1.25 per share, according to Symrise.

What does October 28 bring?

The scheduled third-quarter statement is the next dated operating checkpoint. Symrise's financial calendar identifies October 28, 2026 as the reporting date, while the same calendar lists a virtual management roadshow for that day, according to Symrise. Analysts are already split on valuation: Bernstein analyst James Hooper maintained a Neutral rating and a EUR 99.00 target on October 20, 2026, as reported by MarketScreener.

Stock sits below its yearly high

The EUR 100.40 quote was EUR 2.45 below Symrise's 52-week high of EUR 102.85, a distance of 2.38 percent. The 52-week low was EUR 64.70, and the reported volume was 154,821 shares on October 26, 2026. The market capitalization was EUR 13.8 billion, and the price-to-earnings ratio was 37.71 on the same date.

Valuation against industry peers

Symrise traded at 37.71 times earnings with a market capitalization of EUR 13.8 billion on October 26, 2026. Givaudan (SIX, CHF): down 1.33 percent, P/E 29.27, market capitalization CHF 36.4 billion. DSM-Firmenich (Euronext Amsterdam, EUR): down 0.32 percent, market capitalization EUR 26.5 billion.

Price and next date

The October 28 reporting date is the immediate calendar point for investors. The stock's position 2.38 percent below its 52-week high leaves the upcoming update relevant to both revenue growth and margin quality.

The latest Xetra quote was EUR 100.40 on October 26, 2026 at 5:19 p.m. CET, down 1.57 percent versus the Xetra close of EUR 102.00 on October 23, 2026.